Cullen Investment Group’s Edwards Lifesciences EW Stock Holding History

Cullen Investment Group’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,408	Closed	-$273K	–	182
2026 Q1	$273K	Sell	3,408 -5,332	-61%	-$440K	0.04%	158
2025 Q4	$744K	Sell	8,740 -13,494	-61%	-$1.11M	0.1%	115
2025 Q3	$1.71M	Buy	22,234 +483	+2%	+$37.7K	0.23%	75
2025 Q2	$1.7M	Buy	21,751 +828	+4%	+$61.8K	0.24%	76
2025 Q1	$1.52M	Buy	20,923 +380	+2%	+$27.2K	0.23%	80
2024 Q4	$1.52M	Buy	20,543 +739	+4%	+$51.7K	0.22%	77
2024 Q3	$1.31M	Buy	19,804 +348	+2%	+$25.3K	0.19%	91
2024 Q2	$1.8M	Buy	19,456 +197	+1%	+$17.4K	0.29%	69
2024 Q1	$1.82M	Buy	19,259 +1,171	+6%	+$98.4K	0.29%	70
2023 Q4	$1.38M	Buy	+18,088	New	+$1.26M	0.24%	85

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

Cullen Investment Group's EW Position: Q2 2026 in Review

Cullen Investment Group sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 3,408 shares — an estimated $273K sold.

Cullen Investment Group first reported a position in EW in Q4 2023 and held it in 10 quarters. The position peaked at $1.82M in Q1 2024. 295 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Cullen Investment Group reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
Cullen Investment Group sold 3,408 Edwards Lifesciences shares in Q2 2026, an estimated $273K.
Cullen Investment Group first reported a position in Edwards Lifesciences in Q4 2023 and held it in 10 quarters.
Cullen Investment Group's Edwards Lifesciences position peaked at $1.82M in Q1 2024.
295 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Cullen Investment Group's 13F filing for Q2 2026, filed 9 Jul 2026.